An Updated Overview on Targeting Nrf2 by Natural Compounds Against Doxorubicin‐Induced Cardiotoxicity
Phytotherapy Research · 2026-07 · 40 (7) · 4147-4170
DOI: 10.1002/ptr.70290 ↗At a glance
Übersichtsarbeit in Phytotherapy Research, published online on 2026-04-28. Written by Fatemeh Yarmohammadi and 1 co-authors. Institution: Razi Drug Research Center, Iran University of Medical Sciences, Tehran, Iran. Major MEDLINE topics: NF-E2-Related Factor 2, Cardiotoxicity, Doxorubicin, Biological Products. Cited 3 times so far (Crossref); 150 references. Funded by: Kermanshah University of Medical Sciences, Health Technology Institute, Medical Biology Research Center, Mashhad University of Medical Sciences, National Institute for Medical Research Development.
Abstract (original language)
Doxorubicin (DOX) is an effective and widely used chemotherapeutic agent against various cancers. However, its clinical utility is limited by an irreversible cardiotoxicity. The underlying mechanisms of DOX‐induced heart damage are complex and multifactorial, involving oxidative stress and reactive oxygen species (ROS) generation and mitochondrial dysfunction that culminate in cardiomyocyte injury and programmed cell death. Central to the cellular antioxidant defense is the nuclear factor erythroid 2‐related factor 2 (Nrf2), which regulates the expression of key antioxidant enzymes. Activation of Nrf2 enhances cellular resilience by mitigating oxidative stress and lipid peroxidation induced by DOX. Natural compounds (NCs) have shown promise in up‐regulating Nrf2 and stabilizing antioxidant defenses. This review provides an update and comprehensive analysis of 51 studies published from 2020 to 2025 investigating the role of plant‐derived compounds in protecting against DOX‐induced cardiotoxicity through activation of Nrf2. All NCs included in this review are extracted from various plants and activate Nrf2 via multiple upstream pathways, such as Keap1‐Nrf2, AMPK/Nrf2, SIRT1/Nrf2, and PI3K/AKT/Nrf2. These pathways collectively enhance antioxidant capacity, improve mitochondrial function, maintain iron homeostasis, and inhibit apoptosis and ferroptosis. The findings emphasize the diverse mechanisms through which plant‐based NCs target Nrf2 signaling, highlighting their significant therapeutic potential to reduce DOX‐induced cardiotoxicity.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Razi Drug Research Center, Iran University of Medical Sciences, Tehran, Iran.
- Medical Biology Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
- Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
- Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
ORCID profiles: Fatemeh Yarmohammadi, Gholamreza Karimi
Funding
- Kermanshah University of Medical Sciences, Health Technology Institute, Medical Biology Research Center
- Mashhad University of Medical Sciences
- National Institute for Medical Research Development
- Kermanshah University of Medical Sciences
Cite
APA
Yarmohammadi, F., & Karimi, G. (2026). An Updated Overview on Targeting Nrf2 by Natural Compounds Against Doxorubicin‐Induced Cardiotoxicity. Phytotherapy Research, 40(7), 4147-4170. https://doi.org/10.1002/ptr.70290
Vancouver
Yarmohammadi F, Karimi G. An Updated Overview on Targeting Nrf2 by Natural Compounds Against Doxorubicin‐Induced Cardiotoxicity. Phytotherapy Research. 2026;40(7):4147-4170. doi:10.1002/ptr.70290
BibTeX
@article{Yarmohammadi2026,
author = {Yarmohammadi, Fatemeh and Karimi, Gholamreza},
title = {An Updated Overview on Targeting Nrf2 by Natural Compounds Against Doxorubicin‐Induced Cardiotoxicity},
journal = {Phytotherapy Research},
year = {2026},
volume = {40},
number = {7},
pages = {4147--4170},
doi = {10.1002/ptr.70290}
}
EUVIMED